Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.

Here’s a table showing how ASX-listed healthcare stocks have been performing.

CODE	COMPANY	PRICE	1 WEEK RETURN %	6 MONTH RETURN %	1 YEAR RETURN %	MARKET CAP
ADO	Anteotech Ltd	0.23	31.4%	17.9%	109.1%	$394,808,878
AT1	Atomo Diagnostics	0.195	18.2%	-9.3%	-35.0%	$71,520,809
AVE	Avecho Biotech Ltd	0.015	15.4%	-11.8%	-16.7%	$27,541,748
GSS	Genetic Signatures	1.425	14.0%	9.0%	-13.6%	$191,748,970
PTX	Prescient Ltd	0.225	12.5%	-4.3%	240.9%	$152,771,903
BIT	Biotron Limited	0.091	11.0%	85.7%	16.7%	$63,173,944
VBS	Vectus Biosystems	1.3	10.2%	-10.3%	15.0%	$42,311,684
PGC	Paragon Care Limited	0.325	8.3%	12.1%	47.7%	$114,205,227
BOT	Botanix Pharma Ltd	0.058	7.4%	-3.3%	-53.6%	$57,415,382
SHG	Singular Health	0.295	7.3%	11.3%	0.0%	$18,761,110
EZZ	EZZ Life Science	0.525	7.1%	11.7%	0.0%	$6,507,600
ZNO	Zoono Group Ltd	0.395	6.8%	-3.7%	-69.8%	$61,992,265
IHL	Incannex Healthcare	0.535	5.9%	-2.7%	269.0%	$610,306,642
BWX	BWX Limited	4.5	5.9%	0.7%	10.3%	$691,818,929
CAJ	Capitol Health	0.365	5.8%	-1.4%	30.4%	$380,409,392
DVL	Dorsavi Ltd	0.019	5.6%	-13.6%	-50.0%	$6,723,744
RGS	Regeneus Ltd	0.077	5.5%	10.0%	-43.0%	$22,982,769
VTI	Vision Tech Inc	0.9	5.3%	-4.3%	-62.5%	$21,981,015
NYR	Nyrada Inc.	0.215	4.9%	-10.4%	-6.5%	$27,038,626
IIQ	Inoviq Ltd	1.075	4.9%	-4.4%	64.1%	$98,920,105
PXS	Pharmaxis Ltd	0.11	4.8%	0.0%	29.4%	$57,492,678
RNO	Rhinomed Ltd	0.27	3.8%	12.5%	54.3%	$74,045,603
AHC	Austco Healthcare	0.145	3.6%	3.6%	45.0%	$39,786,453
MDC	Medlab Clinical Ltd	0.145	3.6%	-14.7%	-42.0%	$49,615,472
MVP	Medical Developments	5.235	3.5%	6.8%	-21.6%	$369,230,695
NXS	Next Science Limited	1.22	3.4%	0.0%	-6.2%	$241,528,169
DOC	Doctor Care Anywhere	0.46	3.4%	-14.8%	-61.7%	$82,739,800
PBP	Probiotec Limited	2.22	3.3%	6.7%	-1.3%	$180,537,961
VLS	Vita Life Sciences..	1.93	3.2%	12.2%	93.0%	$101,619,541
HXL	Hexima	0.37	2.8%	8.8%	111.4%	$58,573,650
IVX	Invion Ltd	0.0185	2.8%	-11.9%	85.0%	$121,913,759
ANP	Antisense Therapeut.	0.185	2.8%	-11.9%	42.3%	$124,983,838
RCE	Recce Pharmaceutical	0.97	2.6%	13.5%	-7.6%	$166,836,333
PSQ	Pacific Smiles Grp	2.77	2.6%	-7.0%	10.8%	$426,083,774
1AD	Adalta Limited	0.082	2.2%	-4.8%	-28.0%	$24,949,244
PAA	Pharmaust Limited	0.092	2.2%	-8.0%	-12.4%	$28,839,027
CYP	Cynata Therapeutics	0.47	2.2%	-8.7%	-31.9%	$64,474,467
PCK	Painchek Ltd	0.053	1.9%	6.0%	-33.8%	$57,722,045
CAN	Cann Group Ltd	0.29	1.8%	-3.3%	-41.4%	$99,423,533
CBL	Control Bionics	0.425	1.2%	-5.6%	-57.5%	$20,132,362
OPT	Opthea Limited	1.28	0.4%	5.8%	-33.7%	$446,962,886
ALT	Analytica Limited	0.002	0.0%	33.3%	0.0%	$6,920,702
ONE	Oneview Healthcare	0.25	0.0%	-9.1%	455.6%	$129,100,328
BDX	Bcaldiagnostics	0.13	0.0%	-16.1%	0.0%	$17,098,453
SCU	Stemcell United Ltd	0.014	0.0%	0.0%	-12.5%	$14,606,489
IPD	Impedimed Limited	0.17	0.0%	-5.6%	30.8%	$293,009,063
ICS	ICSGlobal Limited	0.575313	0.0%	0.0%	6.8%	$6,054,605
FFC	Farmaforce Ltd	0.046	0.0%	-16.4%	-45.9%	$6,011,325
AN1	Anagenics Limited	0.056	0.0%	-8.2%	-42.7%	$12,332,177
AHK	Ark Mines Limited	0.034	0.0%	0.0%	0.0%	$88,944
CTE	Cryosite Limited	0.405	0.0%	12.5%	11.0%	$19,767,873
PYC	PYC Therapeutics	0.14	0.0%	-6.7%	0.0%	$445,329,654
RAD	Radiopharm	0.37	0.0%	0.0%	0.0%	$43,166,784
RAD	Radiopharm	0.37	0.0%	0.0%	0.0%	$43,166,784
LBT	LBT Innovations	0.097	0.0%	2.1%	-15.7%	$28,044,171
TD1	Tali Digital Limited	0.02	0.0%	-13.0%	-56.5%	$17,240,257
1ST	1St Group Ltd	0.013	0.0%	-7.1%	-59.5%	$6,549,087
IMC	Immuron Limited	0.11	0.0%	-12.0%	-54.2%	$26,196,810
GTG	Genetic Technologies	0.0055	0.0%	-8.3%	-21.4%	$46,169,826
S66	Star Combo	0.255	0.0%	-8.9%	-27.1%	$34,298,260
BPH	BPH Energy Ltd	0.037	0.0%	-15.9%	5.7%	$24,602,017
PAL	Palla Pharma Ltd	0.295	0.0%	-25.3%	-59.4%	$47,764,383
ACR	Acrux Limited	0.0995	-0.5%	-17.1%	-43.1%	$28,368,034
CMP	Compumedics Limited	0.3925	-0.6%	12.1%	-13.7%	$69,093,550
TLX	Telix Pharmaceutical	7.83	-0.9%	9.7%	99.2%	$2,306,239,826
NC6	Nanollose Limited	0.099	-1.0%	-13.9%	90.4%	$14,888,637
IMM	Immutep Ltd	0.48	-1.0%	-11.1%	23.1%	$409,978,944
PAR	Paradigm Bio.	1.92	-1.3%	-10.7%	-23.2%	$430,156,053
PIQ	Proteomics Int Lab	1.115	-1.3%	16.1%	36.0%	$119,391,139
IBX	Imagion Biosys Ltd	0.072	-1.4%	-17.2%	-42.4%	$80,713,334
MVF	Monash IVF Group Ltd	0.985	-1.5%	5.9%	25.5%	$385,738,492
UBI	Universal Biosensors	0.88	-1.7%	-5.4%	125.6%	$156,489,084
CHM	Chimeric Therapeutic	0.26	-1.9%	-10.3%	0.0%	$57,298,102
SDI	SDI Limited	1	-2.0%	-6.5%	24.2%	$119,459,858
KZA	Kazia Therapeutics	1.105	-2.2%	-27.8%	-5.6%	$143,920,558
ARX	Aroa Biosurgery	1.0175	-2.6%	-11.5%	-7.5%	$350,853,536
NOX	Noxopharm Limited	0.365	-2.7%	-24.0%	-18.9%	$99,360,903
PAB	Patrys Limited	0.036	-2.7%	-14.3%	72.2%	$71,985,288
ALA	Arovella Therapeutic	0.036	-2.7%	-18.2%	0.0%	$17,313,152
MDR	Medadvisor Limited	0.355	-2.7%	-6.6%	-5.3%	$143,587,400
ATX	Amplia Therapeutics	0.17	-2.9%	-15.0%	-25.3%	$30,043,476
ZLD	Zelira Therapeutics	0.032	-3.0%	-17.9%	-64.4%	$38,286,949
SOM	SomnoMed Limited	2.13	-3.2%	-7.8%	2.4%	$176,277,341
CU6	Clarity Pharma	0.715	-3.4%	-24.7%	0.0%	$116,643,365
RSH	Respiri Limited	0.057	-3.4%	-3.4%	-52.5%	$41,201,925
PNV	Polynovo Limited	1.515	-3.5%	4.8%	-61.2%	$955,705,724
ILA	Island Pharma	0.26	-3.7%	-7.1%	0.0%	$11,243,223
ACW	Actinogen Medical	0.13	-3.7%	-23.5%	584.2%	$230,730,057
CDX	Cardiex Limited	0.05	-3.8%	-12.3%	-3.8%	$54,951,126
ALC	Alcidion Group Ltd	0.25	-3.8%	-27.2%	41.6%	$317,659,197
HCT	Holista CollTech Ltd	0.048	-4.0%	-11.1%	-31.4%	$13,216,756
CGS	Cogstate Ltd	2.3	-4.2%	-0.9%	101.8%	$396,983,827
BNO	Bionomics Limited	0.115	-4.2%	-4.2%	-17.0%	$157,146,809
DXB	Dimerix Ltd	0.23	-4.2%	-14.8%	27.8%	$73,800,943
ATH	Alterity Therap Ltd	0.022	-4.3%	-15.4%	-29.0%	$52,951,241
OSX	Osteopore Limited	0.22	-4.3%	-2.2%	-56.4%	$26,971,695
RAC	Race Oncology Ltd	3.27	-4.4%	-3.3%	89.0%	$515,006,646
JTL	Jayex Technology Ltd	0.021	-4.5%	-8.7%	-50.0%	$5,233,799
AC8	Auscann Grp Hlgs Ltd	0.082	-4.7%	-21.9%	-50.3%	$36,565,410
4DX	4Dmedical Limited	1.23	-4.7%	3.8%	-45.6%	$254,926,031
MX1	Micro-X Limited	0.255	-4.7%	-19.0%	-29.2%	$119,633,214
CYC	Cyclopharm Limited	1.59	-4.8%	-14.3%	-36.4%	$148,932,843
OSP	Osprey Med Inc	0.565	-5.0%	-29.8%	-71.8%	$14,368,784
MXC	Mgc Pharmaceuticals	0.037	-5.1%	-19.6%	54.2%	$99,847,053
NEU	Neuren Pharmaceut.	3.61	-5.2%	93.0%	182.0%	$487,487,166
OIL	Optiscan Imaging	0.18	-5.3%	-10.0%	56.5%	$111,453,408
TRU	Truscreen	0.07	-5.4%	-11.4%	0.0%	$25,400,638
M7T	Mach7 Tech Limited	0.82	-5.7%	-7.9%	-32.2%	$196,947,422
MEM	Memphasys Ltd	0.092	-6.1%	-12.4%	-34.3%	$74,464,764
NSB	Neuroscientific	0.305	-6.2%	-14.1%	17.3%	$43,758,851
TRP	Tissue Repair	0.525	-6.3%	-18.6%	0.0%	$21,074,858
RAP	Resapp Health Ltd	0.058	-6.5%	5.5%	-30.1%	$51,551,825
GLH	Global Health Ltd	0.345	-6.8%	-9.2%	-20.7%	$21,511,569
OSL	Oncosil Medical	0.038	-7.3%	-19.1%	-69.6%	$30,109,045
OCC	Orthocell Limited	0.5	-7.4%	-3.8%	22.0%	$96,639,165
EXL	Elixinol Wellness	0.073	-7.6%	-25.5%	-59.4%	$23,693,338
VHT	Volpara Health Tech	0.99	-7.9%	-7.0%	-25.3%	$247,689,165
ICR	Intelicare Holdings	0.081	-8.0%	-8.0%	-66.0%	$3,816,844
ADR	Adherium Ltd	0.011	-8.3%	-8.3%	-52.2%	$24,240,365
LCT	Living Cell Tech.	0.0055	-8.3%	-31.3%	-58.9%	$4,916,028
AGH	Althea Group	0.215	-8.5%	-20.4%	-48.2%	$67,172,670
MMJ	MMJ Group Hlds Ltd	0.059	-9.2%	-15.7%	-50.8%	$13,107,377
IRX	Inhalerx Limited	0.077	-9.4%	-23.0%	-3.8%	$12,971,956
TSN	The Sust Nutri Grp	0.22	-10.2%	-6.4%	-36.2%	$21,848,937
EPN	Epsilon Healthcare	0.079	-10.2%	-28.2%	-68.4%	$16,703,021
BXN	Bioxyne Ltd	0.026	-10.3%	8.3%	116.7%	$16,643,780
LDX	Lumos Diagnostics	0.68	-10.5%	-20.0%	0.0%	$103,794,623
CPH	Creso Pharma Ltd	0.079	-11.2%	-21.0%	-58.4%	$93,203,383
NTI	Neurotech Intl	0.053	-11.7%	-20.9%	35.9%	$36,952,402
AMT	Allegra Orthopaedics	0.15	-11.8%	-23.1%	-59.5%	$15,668,880
RHT	Resonance Health	0.1	-13.0%	-4.8%	-54.5%	$46,085,198
OVN	Oventus Medical Ltd	0.08	-13.0%	-17.5%	-61.0%	$19,338,123
RHY	Rhythm Biosciences	1.48	-14.5%	-21.3%	81.0%	$309,238,997
EYE	Nova EYE Medical Ltd	0.305	-15.3%	-20.8%	-9.0%	$44,393,906
IMU	Imugene Limited	0.41	-15.5%	-27.4%	327.1%	$2,419,148,071
MEB	Medibio Limited	0.005	-28.6%	-28.6%	-37.5%	$10,305,256
IDT	IDT Australia Ltd	0.28	-41.7%	-34.9%	64.7%	$69,559,449
ONT	1300 Smiles Limited	0	-100.0%	-100.0%	-100.0%	$168,827,115

The biggest winner this fortnight was Anteotech (ASX:ADO).

Shares are up 31.4% on news of a $1.96m refund under the Federal Government’s Research & Development Tax Incentive scheme.

The rebate relates to R&D activities conducted by AnteoTech in both its Life Science and Energy divisions for the 2021 financial year.

ADO says funds will be reinvested into the continued development of its lateral flow test product offerings for the EuGeni platform and the AnteoX program, which is targeting electrode coating cohesion of lithium-ion battery electrodes.

The EuGeni platform is Anteoch’s compact solution for rapid point-of-care testing – it is a highly interactive, user-friendly reader system underpinned by patented AnteoBind™ nanoparticle technology and can be easily transported into clinics.

Atomo Diagnostics (ASX:AT1) was up 18.2% on no news while Avecho Biotech (ASX:AVE) gained 15.4% after securing a product licence and supply agreement with Medterra Pharma for its CBD soft-gel capsule for the oral treatment of arthritis.

Medterra is one of the most successful CBD companies in the United States and plans to develop AVE’s product with the intent to support FDA approval.

Avecho said this marked a “strategic step forward” in its ambitions to secure Food and Drug Administration approval for its soft-gel CBD product, which will occur in parallel to existing work to register the product for sleep indications with the Therapeutic Goods Administration.

Up 14% was Genetic Signatures (ASX:GSS) with a forecast revenue projection of $21m targeted for the first quarter of 2022.

Prescient Therapeutics (ASX:PTX) was up 12.5% on no news and Biotron (ASX:BIT) saw an 11% rise following an update to market on an extension to its phase-2 HIV-1 trial.

The trial incorporates PTX’s antiviral drug BIT225 and the extension includes a second Australian site – St Vincent’s Hospital Human Research Ethics Committee has approved the study and will be bringing on board a second key trial site at St Vincent’s Hospital in Sydney.

Who flatlined?

Amongst the 21 flatliners was Star Combo (ASX:S66), Tali Digital (ASX:TD1), and PYC Therapeutics (ASX:PYC).

Another flatliner was Anagenics (ASX:AN1), formerly named Cellmid.

AN1 said the inspiration for the recent name change traces back to the Greek word for regeneration, anagennisi, and reflects the company’s story, business, and future aspirations.

Who’s the biggest loser?

The biggest dipper was IDT Australia (ASX:IDT).

Its shares dropped 41.7% in the past fortnight when news broke out that IDT’s ATM submission had not been selected to progress to the next stage.

The Australian Government announced that a new manufacturing facility will be built in Australia in collaboration with Moderna to produce respiratory mRNA vaccines in the onshore mRNA Approach To Market process.

IDT is now liaising directly with the Australian and Victorian governments to better understand their approach to supporting Australia’s mRNA translation and manufacturing ecosystem.

The second biggest loser was Medibio (ASX:MEB) with shares down 28.6% and Imugene (ASX:IMU) came third at 15.5%.